PD-1 Status in CD8 + T Cells Associates with Survival and Anti-PD-1 Therapeutic Outcomes in Head and Neck Cancer von Kansy, Benjamin A, Concha-Benavente, Fernando, Srivastava, Raghvendra M, Jie, Hyun-Bae, Shayan, Gulidanna, Lei, Yu, Moskovitz, Jessica, Moy, Jennifer, Li, Jing, Brandau, Sven, Lang, Stephan, Schmitt, Nicole C, Freeman, Gordon J, Gooding, William E, Clump, David A, Ferris, Robert L

Volltext

T cell receptor richness in peripheral blood increases after cetuximab therapy and correlates with therapeutic response von Kansy, Benjamin A., Shayan, Gulidanna, Jie, Hyun-Bae, Gibson, Sandra P., Lei, Yu L., Brandau, Sven, Lang, Stephan, Schmitt, Nicole C, Ding, Fei, Lin, Yan, Ferris, Robert L.

Volltext

CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis von Jie, Hyun-Bae, Schuler, Patrick J, Lee, Steve C, Srivastava, Raghvendra M, Argiris, Athanassios, Ferrone, Soldano, Whiteside, Theresa L, Ferris, Robert L

Volltext

PD-1/SHP-2 inhibits Tc1/Th1 phenotypic responses and the activation of T cells in the tumor microenvironment von Li, Jing, Jie, Hyun-Bae, Lei, Yu, Gildener-Leapman, Neil, Trivedi, Sumita, Green, Tony, Kane, Lawrence P, Ferris, Robert L

Volltext

Cetuximab-Activated Natural Killer and Dendritic Cells Collaborate to Trigger Tumor Antigen―Specific T-cell Immunity in Head and Neck Cancer Patients von SRIVASTAVA, Raghvendra M, LEE, Steve C, FERRIS, Robert L, ANDRADE, Pedro A, LORD, Christopher A, JIE, Hyun-Bae, DAVIDSON, H. Carter, LOPEZ-ALBAITERO, Andrés, GIBSON, Sandra P, GOODING, William E, FERRONE, Soldano

Volltext

Increased PD-1 + and TIM-3 + TILs during Cetuximab Therapy Inversely Correlate with Response in Head and Neck Cancer Patients von Jie, Hyun-Bae, Srivastava, Raghvendra M, Argiris, Athanassios, Bauman, Julie E, Kane, Lawrence P, Ferris, Robert L

Volltext

Tumor-infiltrating Tim-3+ T cells proliferate avidly except when PD-1 is co-expressed: Evidence for intracellular cross talk von Li, Jing, Shayan, Gulidanna, Avery, Lyndsay, Jie, Hyun-Bae, Gildener-Leapman, Neil, Schmitt, Nicole, Lu, Bin Feng, Kane, Lawrence P., Ferris, Robert L.

Volltext

Tumor Antigen-Specific Monoclonal Antibodies and Induction of T-Cell Immunity von Trivedi, Sumita, Jie, Hyun-Bae, Ferris, Robert L

Volltext

STAT1-Induced HLA Class I Upregulation Enhances Immunogenicity and Clinical Response to Anti-EGFR mAb Cetuximab Therapy in HNC Patients von Srivastava, Raghvendra M, Trivedi, Sumita, Concha-Benavente, Fernando, Hyun-Bae, Jie, Wang, Lin, Seethala, Raja R, Branstetter, 4th, Barton F, Ferrone, Soldano, Ferris, Robert L

Volltext

Role of dendritic cell maturation factors produced by human invariant NKT cells in immune tolerance von Lee, Hyeong‐Woo, Jie, Hyun Bae, Bollyky, Paul L., Sarracino, David, Kim, Tong‐Soo, Wilson, Brian S.

Volltext

Activation of Plasmacytoid Dendritic Cells with TLR9 Agonists Initiates Invariant NKT Cell-Mediated Cross-Talk with Myeloid Dendritic Cells von Montoya, Carlos J, Jie, Hyun-Bae, Al-Harthi, Lena, Mulder, Candice, Patino, Pablo J, Rugeles, Maria T, Krieg, Arthur M, Landay, Alan L, Wilson, S. Brian

Volltext

Porcine FcγRIII isoforms are generated by alternative splicing von Jie, Hyun-Bae, Yim, Daesong, Kim, Yoon B.

Volltext

Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment von Kansy, Benjamin A, Lin, Yan, Ding, Fei, Gibson, Sandra Poveda, Jie, Hyun-Bae, Ferris, Robert L

Volltext

STAT1 contributes to HLA class I upregulation and CTL reactivity after anti-EGFR mAb cetuximab therapy in head and neck cancer patients von Srivastava, Raghvendra M, Jie, Hyun-bae, Ferrone, Soldano, Ferris, Robert L

Volltext

TIM-3+ T cells are not exhausted but activated cells in the tumor microenvironment von Jie, Hyun-Bae, Li, Jing, Srivastava, Raghvendra, Ferris, Robert L

Volltext

Level of PD-1 expression on CD8+ T cells influence prognosis and respond to PD-1 therapy in a murine model von Kansy, Benjamin A, Srivastava, Raghvendra M, Jie, Hyun-Bae, Shayan, Gulidanna, Lei, Yu, Li, Jing, Gooding, William, Brandau, Sven, Lang, Stephan, Schmitt, Nicole, Freeman, Gordon J, Clump, David A, Ferris, Robert L

Volltext

Co-targeting of delta-like ligand 4 (DLL4) and vascular endothelial growth factor a (VEGF) with programmed death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor i... von Srivastava, Minu, Murriel, Christopher, Yun, Rui, Mayes, Erin, Jie, Hyun-Bae, Axelrod, Fumiko, Xie, Ming-Hong, Bentley, Trevor, Cancilla, Belinda, Tam, Raymond, O'Young, Gilbert, Kapoun, Ann, Lewicki, John, Hoey, Tim, Gurney, Austin, Inkyung, Park Angie

Volltext

Molecular cloning, expression pattern and chromosomal mapping of pig CD69 von Yim, Daesong, Sotiriadis, John, Kim, Kwan-Suk, Shin, Soon-Cheon, Jie, Hyun-Bae, Rothschild, Max F, Kim, Yoon B

Volltext

The role of NK cells and NK cell receptors in autoimmune disease von JIE, Hyun-Bae, SARVETNICK, Nora

Volltext

Natural killer: dendritic cell activation using anti-CD137 mAb improves cetuximab mediated innate and adaptive immune responses in head and neck cancer (TUM7P.948) von Srivastava, Raghvendra, Jie, Hyun-bae, Li, Jing, Ferris, Robert

Volltext